Status:
ACTIVE_NOT_RECRUITING
AGRA Before and After Liver Transplantation
Lead Sponsor:
Medical University of Graz
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18-80 years
Brief Summary
The immune system is impaired in liver cirrhotic patients, which is associated with a high risk for bacterial infections and worse outcome. A novel biomarker, acellular growth retardation ability (AGR...
Detailed Description
Cirrhosis-associated immune dysfunction syndrome (CAIDS) is a well-recognized phenomenon. It affects all immune cells as well as the humoral immune system. Because of this deficiency patients with liv...
Eligibility Criteria
Inclusion
- Patients between 18-80 years
- Listed for liver transplantation (for recipients)
- Liver recipient is included in the study (for donors)
- Informed consent
Exclusion
- Antibiotic therapy with substances active against E. coli at the scheduled blood sampling
Key Trial Info
Start Date :
July 6 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT03446521
Start Date
July 6 2018
End Date
December 1 2026
Last Update
February 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, Medical University of Geraz
Graz, Austria, 8036